Goodsurance
ES

Drug prices & Part D

Spread your Medicare drug costs by month

A free Medicare option lets you pay your prescription costs in monthly installments instead of a big hit at the pharmacy. With the 2026 out of pocket cap at $2,100, it can soften a January spike.

By the Goodsurance editorial teamJune 29, 2026

There is a Medicare option that many people have never heard of, and it can help most if you have a large prescription bill early in the year. It is called the Medicare Prescription Payment Plan. Every Part D drug plan has been required to offer it since 2025, it costs nothing to join, and it is voluntary. Here is how it works. Instead of paying a big amount at the pharmacy counter when you fill an expensive prescription, you pay nothing at the register and the plan spreads your share into capped monthly payments billed across the rest of the year. It does not lower your total drug costs or change your coverage; it only changes the timing, turning one painful month into smaller steady amounts. This matters more in 2026 because of how Part D now works. Your out of pocket spending on covered drugs is capped at $2,100 for the year, and many people hit a large share of that early, for example when an expensive medication refills in January. The payment plan is built for exactly that situation. Who should think about it? People with high cost drugs who would feel a big one time charge, and who would rather budget it monthly. Who can usually skip it? People with low drug costs, since spreading a small amount adds little. People enrolled in 2025 were carried into 2026 automatically, and anyone can opt in at any time by contacting their plan. As you look ahead to the fall enrollment season, it is worth knowing this lever exists.

A free Medicare option lets you pay prescription costs monthly instead of all at once at the pharmacy.

In plain words

Here is a Medicare option many people have never heard of. It is called the Medicare Prescription Payment Plan. It can help if you have a big drug bill early in the year. Every Part D drug plan must offer it. It is free to join, and you choose whether to use it. Here is how it works. Instead of paying a lot at the pharmacy when you fill a costly prescription, you pay nothing there. Your plan spreads your share into smaller monthly bills over the rest of the year. It does not lower your total cost. It only changes when you pay. This helps more in 2026. Your out of pocket cost for covered drugs is capped at $2,100 for the year. Many people reach a big part of that early. So a monthly plan can soften that first hit. Who should think about it? People with costly drugs who do not want one big charge. Who can skip it? People with small drug costs. If you used it in 2025, you were kept in for 2026. Anyone can join any time by calling their plan.

Source: Medicare.gov
Read at the source →

More news

Other stories on what is moving in Medicare.

Drug prices & Part D

Medicare Drug Price Negotiation Rules Are Now Permanent, Federal Register Shows

The CMS-4215-F final rule, published today, converts the negotiation program from administrative guidance into binding federal regulation for every drug-price cycle starting in 2029, and requires Part D plans to cover negotiated-price drugs on their formularies.

November 9, 2026

Drug prices & Part D

Third Medicare Drug Negotiation Cycle Closes, Including Part B Doctor-Office Drugs for the First Time

The formal negotiation period for 15 drugs ended November 1; CMS must publish any agreed-upon maximum fair prices by November 30, including the first-ever negotiated prices for drugs given in doctors' offices.

November 1, 2026

Drug prices & Part D

Average Medicare Part D Stand-Alone Premium Projected to Rise 50 Percent for 2027, KFF Finds

A KFF analysis published today finds the average monthly premium for stand-alone Part D drug plans is on track to climb from 34 dollars to 51 dollars for 2027, with deductibles also rising sharply, for enrollees who do not switch plans before December 7.

October 30, 2026

Drug prices & Part D

Study: Medicare Drug Price Negotiations Cut Costs for Most Enrollees, but Not for Those Already Hitting the Annual Spending Limit

A research letter in Annals of Internal Medicine finds that patients on six of the first ten negotiated Part D drugs saw out-of-pocket costs fall 26 to 49 percent, while patients on the three highest-priced negotiated drugs saw no additional benefit because they were already reaching the annual cap.

October 24, 2026

Drug prices & Part D

A Customs Rule That Would Have Complicated Drug Orders From Canada Is Delayed Three Months

A new paperwork and bonding requirement for international mail containing medications was set to take effect today but was pushed back to January 20, 2027, preserving a cost-saving pathway that many Medicare beneficiaries and other older adults have come to rely on.

October 22, 2026

Drug prices & Part D

CMS Proposes Eliminating the 1-Dollar Generic Drug Copay for the Lowest-Income Medicare Dual Enrollees

A proposed rule published today in the Federal Register would bring the Part D generic drug copayment to zero for full-benefit dual eligible individuals at or below the Federal Poverty Level, starting in 2028.

October 20, 2026